Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
fda
life sciences
national blog main
national top stories
abbvie
akili interactive labs
alkermes
allergan
biotech
boston top stories
bruce leuchter
buprenorphine
cariprazine
click therapeutics
clickotine
clinical trials
david benshoof klein
david klein
digital health
digital medicines
digital therapeutics
eli lilly
europe
europe blog main
europe top stories
felipe jain
jess fiedorowicz
jessica jeffrey
joshua steinerman
karim calis
lumateperone
m health fairview
marc goodman
massachusetts general hospital
national institutes of health (nih)
new york
new york blog main
new york top stories
olanzapine
What
drug
2
×
gain
2
×
medicine
alkermes
announced
antipsychotic
backs
benefits
bets
caveats
click
commonly
designed
digital
effect
example
favor
fda
field
grabbed
latest
makers
making
medicines
momentum
monday
nascent
offer
panel
prescribed
psyche
sanofi
therapeutics
treatment
vote
weighs
weight
won
Language
unset
Current search:
gain
×
drug
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum